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Abstract:  
Background and Purpose: Mild cognitive impairment (MCI) is a prevalent disorder, with a subset of 
patients progressing to dementia each year. While MCI may be subdivided into amnestic or vascular 
types as well as into single or multiple cognitive domain involvement, most prior studies using 
advanced diffusion imaging have not accounted for these categories. The purpose of the current study 
was to determine if the pattern of diffusion tensor imaging (DTI) and diffusion kurtosis imaging 
(DKI) metrics in patients with amnestic MCI (aMCI) correlate to specific cognitive domain 
impairments. 
Methods: Nineteen consecutive patients with aMCI referred for brain MRI were included. All subjects 
underwent neurocognitive testing. A z-score was calculated for each domain and a composite of all 4 
domains. Brain MRI included standard structural imaging and diffusion imaging. Volumetric, DTI, 
and DKI metrics were calculated and statistical analysis was performed with adjustments for multiple 
measures and comparisons. 
Results: Statistically significant correlations between diffusion metrics and cognitive z-scores were 
detected: visuospatial-visuoconstructional z-scores only correlated with alterations in the corpus 
callosum splenium, executive functioning z-scores with the corpus callosum genu, memory testing z-
scores with the left hippocampus, and composite z-scores with the anterior centrum semiovale. 
Conclusion: Neuroimaging studies of patients with aMCI to date have assumed a population with 
homogeneous cognitive impairment. Our results demonstrate selective patterns of regional diffusion 
metric alterations correlate to specific cognitive domain impairments. Future studies should account 
for this heterogeneity, and this may also be useful for prognostication. 
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Introduction 
Mild cognitive impairment (MCI) is a prevalent disorder, affecting 3-19% of adults over 65 years 
old,
1
 and is defined by cognitive decline greater than expected for age and education level with only a 
mild impact upon an individual’s activities of daily living.2 MCI may be subdivided based upon 
etiology – amnestic MCI (aMCI) or vascular MCI,2,3 and aMCI may be further classified as single or 
multiple domain if cognitive domains other than memory are also impaired, such as visuospatial-
visuoconstructional, executive function, or language.
2
 MCI may be conceptualized as a transitional 
stage between mild cognitive decline related to normal aging and dementia.
4
 Patients with MCI 
progress to dementia, generally Alzheimer’s disease (AD), at a rate of up to 18% per year5 and it has 
been estimated that up to 80% of patients with aMCI develop dementia after 6 years.
6
 Therefore, it is 
important both to diagnose MCI and, potentially, to stratify patients into disease subtype as well as 
likelihood and timeline of progressing to dementia. In addition, while clinical diagnosis and research 
studies of patient conversion from aMCI to dementia primarily focus on memory dysfunction, 
impairment across multiple domains, particularly executive function, is prognostic and predicts a 
more rapid decline.
7,8
 
 
Several studies have demonstrated diffusion metric alterations in patients with MCI using advanced 
MRI diffusion techniques, such as diffusion tensor imaging (DTI) and diffusion kurtosis imaging 
(DKI). Two of the most widely reported DTI metrics, fractional anisotropy (FA) and mean diffusivity 
(MD), have been shown to be altered in patients with MCI in comparison to healthy controls. 
Decreased FA and/or increased MD has been reported in the multiple white matter tracts, including 
the corpus callosum and cingulate bundle,
9
 as well as within the hippocampus.
10,11
 Mean kurtosis 
(MK) is a metric of DKI that describes the degree to which a structure deviates from a Gaussian 
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distribution and, therefore, may be simplistically defined as a measure of tissue heterogeneity.
12
 A few 
studies have demonstrated decreased MK in the grey and white matter of patients with MCI.
13-15
  
 
Prior reports of altered diffusion metrics have largely combined patients with MCI or were restricted 
to aMCI and frequently did not consider phenotypic variations in these patient populations. A recent 
study by Liu et al. stratified patients with aMCI into those with restricted memory deficits versus 
patients with impairments in multiple cognitive domains.
16
 They reported that while FA was 
decreased in the right superior longitudinal fasciculus in both aMCI groups compared to control 
subjects, there was a distinct pattern of FA in single domain aMCI compared to multiple domain 
aMCI, with the former group characterized by decreased FA in the left uncinate fasciculus and left 
inferior longitudinal fasciculus and increased FA in the left anterior thalamic radiation. Furthermore, 
these alterations were significantly correlated with the Boston Naming and Trail Making Tests. 
 
The purpose of the current study was to determine if the pattern of DTI and DKI metrics in patients 
with aMCI correlate to impairments in specific cognitive domains. We hypothesize that performance 
in each cognitive domain will correlate with alterations of diffusion metrics in brain region(s) that are 
thought to be primarily responsible for that cognitive function. These specific patterns may eventually 
help predict subclinical deficits and stratify patients with aMCI for future therapeutic interventions. 
 
Methods 
Subjects 
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The study was approved by our Institution Review Board (IRB). Informed consent was not obtained 
for this retrospective study. A total of 19 consecutive patients diagnosed with aMCI and referred for 
brain MRI were included in the study (Table 1). Clinical diagnosis of MCI was made using the 
National Institute on Aging-Alzheimer’s Association guidelines.17 Review of the electronic medical 
record for each patient was performed to assess for the presence or absence of co-morbidities as listed 
in Table 1. 
 
All of the subjects underwent formal neurocognitive testing at our institution, which included the 
Montreal Cognitive Assessment (MoCA) test. In addition, the following tests that assess specific 
cognitive domains were administered to each subject: Benson Figure Copy (visuospatial-
visuoconstructional); Boston Naming Test (language); Controlled Oral Word Association, FAS 
version, and Trail Making Test, part B (executive function); and Word List Recall and Benson Figure 
Delay (memory testing). A z-score was calculated for each of these domains and a composite z-score 
was also calculated, which was the average of the tests of all 4 domains. 
 
Image Acquisition 
All subjects were referred for clinical brain imaging that included standard sequences in addition to 
advanced diffusion imaging. All MR scans were obtained on the same 3T Magnetom Tim Trio 
scanner (Siemens, Erlangen, Germany) including the following sequences: T1 MPRAGE (TR/TE = 
2300/2.74 ms, FoV 256 mm, slice thickness 1.2 mm), T2 FLAIR (TR/TE = 8000/91 ms, FoV 240 
mm, slice thickness 5.0 mm), T2 TSE (TR/TE = 6000/84 ms, FoV 240 mm, slice thickness 5 mm), T2 
GRE (TR/TE = 668/20 ms, FoV 230 mm, slice thickness 5.0 mm), and DTI (TR/TE = 6800/92 ms, 
FoV 220 mm, slice thickness 2.0 mm, b values 0/1000/2000 s/mm
2
, 30 directions). All images were 
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reviewed by a board certified Neuroradiologist and a clinical report was generated separate from the 
analysis described below. 
 
Data Processing and Analysis 
The anatomic T1 MPRAGE images for each subject were processed for volumetric analysis using 
NeuroQuant, an automated segmentation software package that provides volumes for 11 structures: 
forebrain, cortical gray matter, lateral ventricle, inferior lateral ventricle, hippocampus, amygdala, 
caudate, putamen, globi palladi, thalamus, and cerebellum. NeuroQuant has been previously 
demonstrated to reliability segment these structures in comparison to manual segmentation.
18
 
 
Estimates of cerebral small-vessel disease burden for each subject were performed using the technique 
described by Staals et al.
19
 In brief, T2, T2 FLAIR, and T2 GRE images were scored by a 
Neuroradiologist blinded to the cognitive testing results for the following features: lacunes, 
microbleeds, perivascular spaces, and white matter hyperintensities. A composite score from 0 (no 
evidence of small-vessel disease) to 4 (severe disease) was generated for each subject. 
 
Diffusion post-processing was performed using the Diffusion Kurtosis Estimator software.
20
 FA, MD, 
axial diffusivity, radial diffusivity, MK, axial kurtosis, and radial kurtosis maps were generated for 
each subject. These maps were aligned and regions of interest (ROI) were manually drawn on the b0 
images for the following structures: anterior centrum semiovale, posterior centrum semiovale, corpus 
callosum genu, corpus callosum splenium, posterior limb of the internal capsule, thalamus, and 
hippocampus (Figure 1). These ROI were then propagated across all of the diffusion maps and the 
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metric values were recorded. B0 images were chosen for ROI placement as the anatomic structures of 
interest were easily identified on this sequence and the use of b0 images mitigated the effects of 
motion and potential biases introduced during alignment of anatomic sequences to the diffusion maps. 
The Neuroradiologist placing ROI was blinded to the cognitive testing results of the subjects. 
 
Statistical analysis was performed between the volumetric measurements and the subject cognitive 
testing z-scores as well as between the diffusion metrics for each ROI and the subject cognitive 
testing z-scores. Kendall tau coefficients were calculated for each of these. Adjustment for multiple 
measures and comparisons was performed using false discovery rate correction as described by 
Benjamini and Hochberg.
21
 P values < 0.05 were considered significant. 
 
Results 
Cognitive Testing 
The study population z-score mean and standard deviation for each cognitive testing domain and 
MoCA are listed in the Table 2. 
 
Volumetric Analysis 
With the exception of a positive association between left hippocampal volume and a higher 
performance on memory testing, there were no statistically significant correlations between any 
structural volumes calculated by NeuroQuant and the cognitive testing z-scores (Table 3). 
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Furthermore, the combined hippocampal volume for each subject was greater than the age-matched 
5
th
 percentile volume as provided by NeuroQuant. 
 
Cerebral Small-Vessel Disease Burden Analysis 
The average small-vessel disease score for the included subjects was 0.79 with a standard deviation of 
1.08 using the method described by Staals et al. (range 0-4).
19
 As shown in Table 1, only a single 
subject had a prior lacunar infarct. The overall small-vessel disease burden for subjects ranged from 
none to mild. 
 
DTI/DKI Analysis 
Statistically significant correlations were detected between diffusion metrics and cognitive testing z-
scores (Table 4). A higher z-score for each cognitive test indicates higher performance. Therefore, 
negative correlations indicate that this metric is increased in subjects with poor performance and 
positive correlations indicate that this metric is decreased in subjects with poor performance. 
 
Visuospatial-visuoconstructional testing z-scores were solely correlated with alterations in corpus 
callosum splenium diffusion metrics. Corpus callosum splenium MD values were negatively 
correlated and FA and MK values were positively correlated. Performance on executive functioning 
was negatively correlated only with corpus callosum genu MD values and positively correlated with 
FA and MK values. Left hippocampal MD values were negatively correlated only with memory 
testing z-scores. Composite cognitive testing z-score was positively correlated solely with MK values 
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in both the right and left anterior centrum semiovale. No significant correlations were identified for 
brain ROI, diffusion metrics, or cognitive testing z-scores not listed in Table 4. 
 
Discussion 
While prior studies have demonstrated alterations in advanced diffusion metrics in patients with MCI, 
the majority of these have either included all subjects clinically diagnosed with MCI, irrespective of 
their particular cognitive deficit or etiology, or have divided subjects into two broad classifications – 
vascular and amnestic MCI. Here we demonstrate that in patients with aMCI, specific cognitive 
deficits correlate with alterations in diffusion metrics solely in specific brain regions. Our data suggest 
that it is important to consider the heterogeneity of patients with aMCI when designing and 
interpreting neuroimaging studies and the grouping of patients with aMCI with a variety of deficits 
may account for the wide-range of sometimes conflicting alterations in DTI metrics that have been 
described in the literature. Furthermore, if these findings are validated in larger longitudinal studies, 
the specific patterns of diffusion metric alterations may potentially be beneficial in stratifying patients 
by their risk of developing AD or other neurodegenerative disorders. 
 
The correlations described in the current study between DTI/DKI metric alterations and particular 
cognitive domain testing followed an expected pattern. Decreased FA and MK and increased MD 
within the corpus callosum splenium correlated with visuospatial-visuoconstructional z-scores. Given 
that lesion analysis studies map several deficits in figure copying to the parietal and occipital lobes,
22
 
it is not unexpected that the major interhemispheric white matter tracts linking these regions should be 
the only fiber tracts that correlate with impairment in this domain. Similarly, this pattern of diffusion 
metric changes was correlated with executive functioning z-scores, but only within the corpus 
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callosum genu, reflecting the frontal lobe localization of the executive functioning testing used in the 
current study.
23
 Although only left hippocampal MD changes were selectively significantly correlated 
with memory z-scores, with a trend for right hippocampal MD metrics, this is consistent with working 
memory localization to the hippocampus.
24
 It is likely that the right hippocampal metrics did not reach 
significance due to the relative small sample size included in the study. While this is a simplistic 
reduction of the complexity of brain activation that likely occurs with each of the cognitive tests used, 
the patterns of deficits follow the conventional brain localization for each of the domains tested. 
 
Cognitive testing composite z-score was only correlated with MK in the bilateral anterior centrum 
semiovale, which may be a result of the composite score, by its definition, reflecting multiple 
cognitive domains. Our results are similar to those recently described by Liu et al., who also failed to 
identify a specific pattern in DTI metric alterations in patients with multiple domain aMCI. We 
hypothesize that the selective correlation found in the current study between MK and the composite z-
score, which is expected to be higher in patients with multiple domain aMCI, may be driven by those 
subjects with the most widespread alterations as the heterogeneity of specific brain regions and 
diffusion metric correlations may be statistically ‘canceled’ on a group-level.  
 
It is interesting that the standard DTI metrics were not significantly correlated with the composite z-
score, whereas MK was the only metric to correlate with the composite z-score, in addition to MK 
correlated with additional selective brain regions and several cognitive tests (Table 1). In a recent 
study by Gong et al. in patients with aMCI, of the diffusion metrics, MK also was found to have the 
largest number of regions with significant abnormalities in comparison to control subjects.
15
 
Furthermore, MK has also been found to be significantly altered in patients with mild traumatic brain 
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injury at a delayed time point, a time at which conventional DTI metrics were unchanged.
25
 Coupled 
with our results, this suggests that MK may be a more sensitive marker of tissue injury, irrespective of 
etiology. 
 
There are several limitations to the current study. The relatively small sample size limits the number 
of subjects that demonstrated deficits in particular cognitive domains; however, frank deficits in a 
domain were not required as we investigated correlations between the score and imaging metrics. We 
also only used a limited number of cognitive tests for each domain. The tests used do represent some 
of the most commonly used clinical tests and are reflective of the cognitive battery currently used in 
our Memory Clinic. Finally, the presence of small-vessel disease that is present on average in patients 
of the age included in the study may impact the distribution of diffusion metric alterations. However, 
the average small-vessel disease burden of the study population was low (0.78 on a scale of 0-4), 
mitigating the impact of small-vessel disease. Despite these limitations, several imaging metrics were 
correlated with cognitive testing performance in select brain regions proposed to be primarily 
involved in that cognitive domain. 
 
Although neuroimaging studies of patients with aMCI have to date have implicitly assumed a 
homogeneous patient population in reference to cognitive impairment, the current study demonstrates 
that there is a selective pattern of regional diffusion metric alterations that correlate to specific 
cognitive domain testing. This heterogeneity should be considered in future studies and, with further 
study, may prove useful in prognostication. 
  
  
 
This article is protected by copyright. All rights reserved. 
14 
 
References: 
1. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262-
70. 
2. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-
94. 
3. Sachdev P, Kalaria R, O'Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a 
VASCOG statement. Alzheimer Dis Assoc Disord 2014;28:206-18. 
4. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr 2008;13:45-53. 
5. Kluger A, Ferris SH, Golomb J, et al. Neuropsychological prediction of decline to dementia 
in nondemented elderly. J Geriatr Psychiatry Neurol 1999;12:168-79. 
6. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical 
characterization and outcome. Arch Neurol 1999;56:303-8. 
7. Gross AL, Manly JJ, Pa J, et al. Cortical signatures of cognition and their relationship to 
Alzheimer's disease. Brain Imaging Behav 2012;6:584-98. 
8. Knopman DS, Beiser A, Machulda MM, et al. Spectrum of cognition short of dementia: 
Framingham Heart Study and Mayo Clinic Study of Aging. Neurology 2015;85:1712-21. 
9. Amlien IK, Fjell AM. Diffusion tensor imaging of white matter degeneration in Alzheimer's 
disease and mild cognitive impairment. Neuroscience 2014;276:206-15. 
10. Muller MJ, Greverus D, Dellani PR, et al. Functional implications of hippocampal volume 
and diffusivity in mild cognitive impairment. Neuroimage 2005;28:1033-42. 
  
 
This article is protected by copyright. All rights reserved. 
15 
 
11. Kantarci K, Petersen RC, Boeve BF, et al. DWI predicts future progression to Alzheimer 
disease in amnestic mild cognitive impairment. Neurology 2005;64:902-4. 
12. Jensen JH, Helpern JA. MRI quantification of non-Gaussian water diffusion by kurtosis 
analysis. NMR Biomed 2010;23:698-710. 
13. Gong NJ, Wong CS, Chan CC, et al. Correlations between microstructural alterations and 
severity of cognitive deficiency in Alzheimer's disease and mild cognitive impairment: a diffusional 
kurtosis imaging study. Magn Reson Imaging 2013;31:688-94. 
14. Falangola MF, Jensen JH, Tabesh A, et al. Non-Gaussian diffusion MRI assessment of brain 
microstructure in mild cognitive impairment and Alzheimer's disease. Magn Reson Imaging 
2013;31:840-6. 
15. Gong NJ, Chan CC, Leung LM, et al. Differential microstructural and morphological 
abnormalities in mild cognitive impairment and Alzheimer's disease: Evidence from cortical and deep 
gray matter. Hum Brain Mapp 2017;38:2495-508. 
16. Liu J, Liang P, Yin L, et al. White matter abnormalities in two different subtypes of amnestic 
mild cognitive impairment. PLoS One 2017;12:e0170185 
17. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to 
Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association 
workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-9. 
18. Brewer JB, Magda S, Airriess C, et al. Fully-automated quantification of regional brain 
volumes for improved detection of focal atrophy in Alzheimer disease. AJNR Am J Neuroradiol 
2009;30:578-80. 
  
 
This article is protected by copyright. All rights reserved. 
16 
 
19. Staals J, Makin SD, Doubal FN, et al. Stroke subtype, vascular risk factors, and total MRI 
brain small-vessel disease burden. Neurology 2014;83:1228-34. 
20. Tabesh A, Jensen JH, Ardekani BA, et al. Estimation of tensors and tensor-derived measures 
in diffusional kurtosis imaging. Magn Reson Med 2011;65:823-36. 
21. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful 
approach to multiple testing. J R Stat Soc Series B Methodol 1995;57:289-300. 
22. Chechlacz M, Novick A, Rotshtein P, et al. The neural substrates of drawing: a voxel-based 
morphometry analysis of constructional, hierarchical, and spatial representation deficits. J Cogn 
Neurosci 2014;26:2701-15. 
23. Muller LD, Guhn A, Zeller JB, et al. Neural correlates of a standardized version of the trail 
making test in young and elderly adults: a functional near-infrared spectroscopy study. 
Neuropsychologia 2014;56:271-9. 
24. Bonner-Jackson A, Mahmoud S, Miller J, et al. Verbal and non-verbal memory and 
hippocampal volumes in a memory clinic population. Alzheimers Res Ther 2015;7:61 
25. Grossman EJ, Jensen JH, Babb JS, et al. Cognitive impairment in mild traumatic brain injury: 
a longitudinal diffusional kurtosis and perfusion imaging study. AJNR Am J Neuroradiol 
2013;34:951-7. 
 
  
  
 
This article is protected by copyright. All rights reserved. 
17 
 
 
Table 1. Population demographics and co-morbidities. 
Demographic Number Mean + SD 
Men 8 (42%) 
Women 11 (58%) 
Age (years) 72.7 + 8.6 
Formal education (years) 14.5 + 3.2 
Disease duration (years) 3.9 + 2.3 
Co-morbidity Number 
Hypertension  15 (79%) 
Hyperlipidemia 12 (63%) 
Diabetes 4 (21%) 
Coronary artery disease 3 (16%) 
Tobacco use 4 (21%) 
Obstructive sleep apnea 0 (0%) 
Atrial fibrillation 1 (5%) 
Chronic renal disease 0 (0%) 
Migraine 0 (0%) 
Prior cerebral infarction* 1 (5%) 
Anticardiolipin antibody status 1 (5%) 
*Lacunar infarction. No territorial or large vessel infarctions.  
  
 
This article is protected by copyright. All rights reserved. 
18 
 
Table 2. Cognitive testing population mean scores. 
Cognitive Domain/Test* Mean + SD 
Visuospatial-Visuoconstructional -2.19 + 4.61 
Language -2.02 + 2.52 
Executive Functioning -1.17 + 1.50 
Composite -5.04 + 4.07 
MoCA 19.84 + 5.80 
*MoCA is raw score mean + SD, cognitive domains are z-scores + SD. 
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Table 3. Correlation between NeuroQuant segmentation volumes and cognitive domain z-scores. 
NeuroQuant 
Segmentation 
Cognitive Domain Z-score 
Correlation Estimate (P value) 
 
Visuospatial-
Visuo-
constructional 
Language Executive Memory Composite 
Cortical Gray R 0.40 (0.26) 0.18 (1.00) 0.09 (0.82) 0.16 (0.94) 0.23 (0.68) 
 L 0.32 (0.72) 0.04 (0.97) 0.08 (0.76) 0.20 (0.97) 0.11 (0.91) 
Forebrain R 0.39 (0.29) 0.08 (1.00) 0.21 (0.82) 0.14 (0.94) 0.14 (0.68) 
 L 0.33 (0.72) -0.01 (0.97) 0.24 (0.76) 0.11 (0.97) 0.13 (0.91) 
Hippocampus R -0.01 (1.00) -0.17 (1.00) 0.25 (0.82) 0.38 (0.31) 0.19 (0.68) 
 L -0.06 (0.85) -0.08 (0.97) 0.28 (0.76) 0.56 (0.01)* 0.22 (0.91) 
Amygdala R -0.10 (1.00) -0.04 (1.00) -0.04 (0.82) 0.36 (0.40) 0.09 (0.68) 
 L -0.03 (0.85) 0.01 (0.97) 0.21 (0.76) 0.46 (0.08) 0.19 (0.91) 
Caudate R 0.05 (1.00) -0.31 (0.90) -0.07 (0.82) -0.16 (0.94) -0.14 (0.68) 
 L 0.11 (0.85) -0.29 (0.97) -0.09 (0.76) -0.01 (0.97) -0.12 (0.91) 
Putamen R 0.26 (1.00) 0.04 (1.00) 0.16 (0.82) -0.18 (0.94) 0.10 (0.68) 
 L 0.08 (0.85) 0.13 (0.97) 0.26 (0.76) 0.02 (0.97) 0.14 (0.91) 
Pallidum R 0.16 (1.00) 0.00 (1.00) 0.21 (0.82) 0.03 (0.94) 0.07 (0.68) 
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 L 0.08 (0.85) 0.13 (0.97) 0.18 (0.76) 0.07 (0.97) 0.11 (0.91) 
Thalamus R 0.26 (1.00) 0.11 (1.00) 0.08 (0.82) -0.11 (0.94) 0.20 (0.68) 
 L -0.09 (0.85) -0.26 (0.97) -0.05 (0.76) 0.12 (0.97) 0.02 (0.91) 
Key: right (R), left (L), *p<0.05  
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Table 4. Correlation between cognitive testing z-scores and diffusion metrics. 
Cognitive Test 
ROI 
Diffusion Metric Correlation Estimate P Value 
Visuospatial-Visuoconstructional 
Corpus Callosum 
Splenium 
MD -0.379 0.05* 
FA 0.398 0.04* 
MK 0.507 <0.01* 
Executive Functioning 
Corpus Callosum Genu 
MD -0.283 0.10 
FA 0.603 <0.01* 
MK 0.407 0.02* 
Memory 
Right Hippocampus 
MD -0.322 0.06 
FA 0.172 0.32 
MK -0.244 0.21 
Left Hippocampus 
MD -0.380 0.02* 
FA 0.272 0.12 
MK -0.107 0.88 
Composite Score 
Right Anterior 
Centrum Semiovale 
MD -0.126 0.52 
FA -0.010 0.96 
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MK 0.485 <0.01* 
Left Anterior Centrum 
Semiovale 
MD -0.282 0.15 
FA -0.087 0.65 
MK 0.354 0.04* 
Key: region of interest (ROI), fractional anisotropy (FA), mean diffusivity (MD), mean kurtosis 
(MK), *p<0.05 
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Figure 1. Placement of region of interest (ROI) for diffusion metrics. Fractional anisotropy, mean 
diffusivity, axial diffusivity, radial diffusivity, mean kurtosis, axial kurtosis, and radial kurtosis maps 
were generated for each subject. These maps were aligned and ROI were manually drawn for the 
following structures: anterior centrum semiovale, posterior centrum semiovale, thalamus, corpus 
callosum genu, corpus callosum splenium, posterior limb of the internal capsule, and hippocampus 
(outlined in green). These ROI were then propagated across all of the diffusion maps and the metric 
values were recorded. 
Centrum semiovale Thalamus Genu corpus callosum 
Splenium corpus callosum Internal capsule Hippocampus
